Aaron Galaznik is a highly accomplished healthcare professional with a background in both medicine and business. He completed his Bachelor of Arts in Biology from Harvard University, followed by a Doctor of Medicine from Cornell University and Weill Cornell Medical College. He later pursued an MBA in Management, Healthcare from the prestigious Wharton School at the University of Pennsylvania.

With over 15 years of experience in the pharma and biotech industries, Galaznik has held a variety of key positions, including Senior Director of Real World Data and Analytics and Senior Director of Global Outcomes Research at leading pharmaceutical companies like Pfizer and Millennium: The Takeda Oncology Company. He has also worked as RWE Head of Research at Medidata Solutions, where he used his experience to develop and execute real-world evidence strategies.

Throughout his career, Galaznik has developed a reputation for his exceptional analytical abilities, strategic mindset, and collaborative approach. He has also demonstrated an unwavering commitment to using data-driven insights to drive healthcare innovation, particularly in the areas of oncology and drug development.